Estradiol/levonorgestrel transdermal - Bayer HealthCare Pharmaceuticals

Drug Profile

Estradiol/levonorgestrel transdermal - Bayer HealthCare Pharmaceuticals

Alternative Names: Climara Pro; Estradiol/levonorgestrel transdermal - Schering AG

Latest Information Update: 18 Mar 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bayer HealthCare Pharmaceuticals
  • Developer Bayer HealthCare Pharmaceuticals Inc.
  • Class Estradiol congeners; Estrenes; Hormonal replacements; Norpregnanes; Small molecules
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Menopausal syndrome; Postmenopausal osteoporosis

Most Recent Events

  • 04 Apr 2007 Berlex Inc has been acquired by Bayer HealthCare (MR 9074204)
  • 11 Jul 2006 No development reported - Phase-III for Menopausal syndrome in European Union (Transdermal)
  • 28 Apr 2006 This product is available for licensing worldwide, excluding USA (http://www.schering.de)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top